Taiwan targets blood-borne ‘silent killer’ hepatitis C, which affects 58 million people worldwide

Island’s health education and targeted screening – backed by Gilead Sciences’ research – aims to halt 90 per cent of infections and 65 per cent of HCV deaths by 2025 …
( read original story …)

---